Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
JBIO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
JBIO
Jade Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
JBIO
Jade Biosciences, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
JBIO
Jade Biosciences, Inc.
Change
14.78
▲
+1.45%
Mkt cap
$926.6M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,421.45
▲
+0.86%
Regular session
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 4 '26
JBIO
Jade Biosciences, Inc.
vs
LLY
ELI Lilly & Co
14.78
▲
+1.45%
Price
1,421.45
▲
+0.86%
$926.6M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
JBIO
14.78
▲
+1.45%
vs
LLY
1,421.45
▲
+0.86%
Regular session
Nov 4 '26
Co-movers
daily closes
Method
›
Moved together
JBIO
with
LLY
Uncorrelated: r 0.16 · 501D.
No shared co-movers.
JBIO, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes